References
Original article
Erba, H. P. et al. Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 401, 1571–1583 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. Newly diagnosed AML: quizartinib improves OS. Nat Rev Clin Oncol 20, 504 (2023). https://doi.org/10.1038/s41571-023-00787-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-023-00787-6
- Springer Nature Limited
This article is cited by
-
A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023
Naunyn-Schmiedeberg's Archives of Pharmacology (2024)